Pycnogenol® improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 6, 2009, Pages 537-540

  Steigerwalt, Robert ^a   Belcaro, Gianni ^a   Cesarone, Maria Rosaria ^a   Di Renzo, Andrea ^a   Grossi, Maria Giovanna ^a   Ricci, Andrea ^a   Dugall, Mark ^a   Cacchio, Marisa ^a   Schönlau, Frank ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Horphag Research UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PYCNOGENOL; ANTITHROMBOCYTIC AGENT; FLAVONOID; PYCNOGENOLS;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; EYE PROTECTION; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MORNING DOSAGE; OPHTHALMOSCOPY; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; RETINA BLOOD FLOW; RETINA EDEMA; RETINA MACULA LUTEA; VISION TEST; VISUAL ACUITY; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA MACULA EDEMA; TIME; TREATMENT OUTCOME;

DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HUMANS; LASER-DOPPLER FLOWMETRY; MACULAR EDEMA; MALE; MICROCIRCULATION; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77149164750     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0023     Document Type: Article

References (20)

1. Kohner, E.M. Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet. Med. 25:20-24, 2008.
2. Bhagat, N., Grigorian, R.A., Tutela, A., et al. Diabetic macular edema: Pathogenesis and treatment. Surv. Ophthalmol. 54:1-32, 2009.
3. Rohdewald, P.J. PycnogenolR, French Maritime Pine Bark Extract. In: Dekker, M., ed. Encyclopedia of Dietary Supplement. Informa Healthcare: New York, NY; 2005; pp. 545-553.
4. Nishioka, K., Hidaka, T., Nakamura, S., et al. PycnogenolR, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Hypertension Res. 30:775-780, 2007.
5. Chida, M., Suzuki, K., Nakanishi-Ueda, T., et al. In vitro testing of antioxidants and biochemical end-point in bovine retinal tissue. Ophthalmic Res. 31:407-415, 1999.
6. Nakanishi-Ueda, T., Kamegawa, M., Ishigaki, S., et al. Inhibitory effect of lutein and PycnogenolR on lipid peroxidation in porcine retinal homogenate. J. Clin. Biochem. Nutr. 38:204-210, 2006.
7. Grimm, T., Chovanova, Z., Muchova, J., et al. Inhibition of NF-B activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J. Infl amm. 3:1, 2006.
8. Grimm, T., Schafer, A., and Hogger, P. Antioxidant activity and inhibition of matrix-metalloproteinases by metabolites of maritime pine bark extract (PycnogenolR). Free Rad. Biol. Med. 36:811-822, 2004.
9. Liu, X., Zhou, H.J., and Rohdewald, P. French maritime pine bark extract PycnogenolR dose-dependently lowers glucose in type II diabetes patients. Diabetes Care. 27:839, 2004. (Pubitemid 38280563)
10. Zibadi, S., Rohdewald, P.J., Park, D., and Watson, R.R. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr. Res. 28:315-320, 2008.
11. Schonlau, F., and Rohdewald, P. PycnogenolR for diabetic retinopathy. A review. Int. Ophthal. 24:161-171, 2002.
12. Spadea, L., and Balestrazzi, E. Treatment of vascular retinopathies with PycnogenolR. Phytother. Res. 15:219-223, 2001.
13. Cesarone, M.R., Belcaro, G., Rohdewald, P., et al. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. Angiology. 57:431-436, 2006.
14. Belcaro, G., Cesarone, M.R., Errichi, B.M., et al. Diabetic ulcers: Microcirculatory improvement and faster healing with PycnogenolR. Clin. Appl. Thromb. Hemost. 12:318-323, 2006.
15. Fong, D.S., and Contreras, R. Glitazone use associated with diabetic macular edema. Am. J. Ophthalmol. 147:583-586.e1, 2009.
16. Arcangeli, P. PycnogenolR in chronic venous insufficiency. Fitoter. 71:236-244, 2000.
17. Petrassi, C., Mastromarino, A., and Spartera, C. PycnogenolR in chronic venous insufficiency. Phytomed. 7:383-388, 2000.
18. Schmidtke, I., and Schoop, W. Das hydrostatische Odem und seine medikamentose Beeinflussung. Swiss Med. 6:67-69, 1984.
19. Cesarone, M.R., Belcaro, G., Rohdewald, P., et al. Comparison of pycnogenol and dafl on in treating chronic venous insufficiency: A prospective, controlled study. Clin. Appl. Thromb. Hemost. 12:205-212, 2006. (Pubitemid 44400863)
20. Watson, R.R. Reduction of cardiovascular disease risk factors by French maritime pine bark extract. Cardiovasc. Rev. Rep. 20:326-329, 1999.